Mycogen Corp., a biotechnology firm developing bioinsecticides,...

Mycogen Corp., a biotechnology firm developing bioinsecticides, reported a net loss of $1.5 million, on revenues of $665,124 for the third quarter ended June 30, compared with a net loss of $1.1 million on revenues of $42,604 over the same quarter last year.

The company’s net loss for the fiscal nine months totaled $3.9 million on revenues of $1.2 million, compared with a net loss of $2.9 million on sales of $121,189 over the same three quarters last year.